G R Ramazanov

Plain English
This study looked at how well and safely Revelise (alteplase), a medication for treating ischemic stroke (IS), works in real-life situations. It involved 2,202 patients, mostly around 68 years old, and found that nearly half (49.9%) of them had good outcomes when discharged, rising to 66.4% after 90 days. The results showed that Revelise effectively reduces stroke-related disabilities, even in older patients and those with other health issues. Who this helps: This benefits patients who suffer from ischemic strokes and the doctors treating them.

Plain English
This study looked at how often specific anatomical variations, called Ponticulus posticus and Ponticulus lateralis, occur in patients with traumatic brain injuries. Out of nearly 3,000 patients examined, 40.2% had the Ponticulus posticus, and 8% had the Ponticulus lateralis, with a significant number of cases occurring more frequently in men. These findings are important because they help identify a common anatomical feature that may affect certain treatments and outcomes for patients with brain injuries. Who this helps: This information benefits doctors and healthcare providers treating patients with traumatic brain injuries.

Plain English
This study looked at how well physical rehabilitation and botulinum toxin injections work for patients with facial nerve issues that cause muscle tightness on the healthy side of their face. Researchers treated 146 patients and found that those who received botulinum toxin had a better chance of recovery—80% of them showed improvement compared to only 45% of those who just had physical rehabilitation. This matters because it highlights the potential of botulinum toxin to improve outcomes for patients with severe symptoms. Who this helps: This helps patients with facial nerve neuropathy, especially those experiencing muscle tightness.

Plain English
This study looked at how consistently different experts assess the collateral status in the brains of patients who have had strokes, using CT angiography images from 158 stroke patients. They found that the modified Tan scale had the best level of agreement among reviewers with a score of 0.72, while the other scales scored lower (0.49 for the Miteff scale and 0.59 for the Rosenthal scale). Understanding collateral status is important because it can help predict how severe a patient's neurological problems may be after a stroke. Who this helps: This helps doctors in making better treatment decisions for stroke patients.

Plain English
This study examined how effective physical rehabilitation (PR) and botulinum therapy are for treating complications of facial nerve neuropathy. Researchers looked at 68 patients and found that those receiving botulinum therapy showed a significant reduction in issues like muscle stiffness and involuntary movements, whereas those undergoing physical rehabilitation had some improvement too, but not as substantial. Specifically, in the botulinum group, the severity of complications dropped significantly, and muscle strength improved in many cases. Who this helps: This helps patients suffering from facial nerve issues and their doctors by providing better treatment options.

Plain English
This study focused on a unique case where a patient with an ischemic stroke was treated using a novel drug called non-immunogenic staphylokinase after neutralizing the blood-thinning effects of dabigatran etexilate. The researchers found that this approach could effectively lead to the dissolution of blood clots without the complications typically faced with standard treatments, thus providing a potential new option for stroke therapy. This matters because it expands the treatment possibilities for patients using certain blood thinners, which previously made it risky to use clot-dissolving drugs. Who this helps: This helps patients with ischemic stroke who are on blood thinners.

Plain English
This study looked at how often Kimmerle's anomaly (KA) occurs in people with specific types of bone growth in the neck, known as grades III and IV vertebral artery sulcus ossification. The researchers found that about 8.6% of patients have KA and that the rates differ based on geography, with Europe showing a higher incidence of 10.1% compared to 6.5% in Asia. Understanding these rates is important because while many may not need treatment, some patients with KA may require surgery. Who this helps: This information is useful for doctors and healthcare providers in diagnosing and treating patients with Kimmerle's anomaly.

Plain English
This study focused on patients with issues related to the marginal mandibular branch of the facial nerve, which affects the muscles involved in lowering the lip and chin. Researchers looked at six patients, averaging 40 years old, who struggled with this condition for about 35 days without improvement. They found that those with a change in muscle performance of less than 90% had a good chance of recovery with specific exercises, while those with more severe changes required surgery for improvement. Who this helps: This research benefits patients dealing with facial nerve issues and their doctors by providing clearer treatment options.

Plain English
This study looked at whether amantadine sulfate could help patients with ischemic stroke recover better than standard treatments. Out of 95 patients, those who received amantadine showed improvement in certain recovery measures, especially in those with milder strokes. Although the overall results didn't show significant differences for all patients, those with less severe strokes had better outcomes, which is important for future research. Who this helps: This helps patients with mild ischemic strokes and their doctors in deciding treatment options.

Plain English
This study looked at how dilated cardiomyopathy (DCMP), a condition where the heart becomes enlarged and weak, can lead to ischemic strokes, which happen when blood supply to the brain is blocked. The researchers shared a case of a patient with DCMP who experienced a stroke as a result of this condition. Understanding the link between DCMP and strokes is important because it can help doctors better identify and manage patients at risk of stroke. Who this helps: This helps patients with dilated cardiomyopathy and their doctors.

Plain English
This study looked at how well brain blood flow can be measured using a special type of CT scan in patients who have just had an ischemic stroke. Researchers found that within the first 3 hours after the stroke, there were clear differences in blood flow between the damaged part of the brain and the healthy side, and these differences continued for 24 hours. Understanding these blood flow patterns can help doctors make better treatment decisions, even for patients outside the usual treatment time frame of 3 to 4.5 hours after a stroke. Who this helps: This helps patients who have suffered an ischemic stroke.

Plain English
This study looked at how certain markers in the body relate to the risk of complications and death after an ischemic stroke, which occurs when blood flow to the brain is blocked. It involved 62 patients and found that higher levels of a substance called rennin indicated a higher risk of severe bleeding in the brain, while higher levels of fibrinogen on day 4 could predict a negative outcome. These findings are significant because they help doctors identify which patients are at a greater risk of complications, allowing for better management of treatment after a stroke. Who this helps: This helps patients and doctors by providing insights for better stroke care and monitoring.

Plain English
This study looked at how fibrinogen levels in the blood can help predict the risks and effectiveness of a treatment for patients who have had an ischemic stroke. It found that patients with fibrinogen levels below 330 mg/dl had the best recovery rates and the lowest risk of complications, while those with levels above 423 mg/dl faced much higher death rates and poorer recovery. These findings are important because they can guide doctors in assessing stroke patients and deciding on treatment strategies. Who this helps: This helps doctors treating stroke patients.

Plain English
This study examined the relationship between certain markers in the blood and the occurrence of hemorrhagic transformation (HT) in patients who had ischemic strokes. Researchers found that on the first day after the stroke, patients who experienced HT had significantly higher levels of renin, endothelin 1-21, and neuron-specific enolase compared to those who did not have HT. Understanding these markers is important because they could help predict which patients are at higher risk for developing serious complications after a stroke. Who this helps: This helps doctors in identifying stroke patients who may face increased risks, allowing for better management and treatment.

Plain English
The study looked at the use of a treatment called thrombolytic therapy (TLT) for patients with ischemic stroke in Russia, involving 691 patients across 48 hospitals. The results showed that 48.6% of patients had a good recovery after three months, while 18.2% died and 6.1% experienced harmful bleeding related to their treatment. These findings highlight the effectiveness and safety of TLT in improving outcomes for stroke patients. Who this helps: This helps stroke patients and their families.

Plain English
This study examined how levels of a protein called fibrinogen in the blood relate to the complications of ischemic stroke in patients who did not receive clot-busting treatment. The researchers found that fibrinogen levels between 200 and 350 mg/dL are associated with a lower chance of complications, while levels above 560 mg/dL signal a higher risk of death from the stroke. Understanding these levels helps doctors predict patient outcomes and manage treatment more effectively. Who this helps: This helps patients and doctors by providing crucial information for stroke management.

Plain English
This study looked at 116 patients who had an ischemic stroke, comparing those who received the most effective treatment (rt-PA) to a control group. It found that high levels of fibrinogen (over 450 mg/dl) and white blood cells (over 78%) were linked to worse outcomes, including the risk of bleeding and death after treatment. Understanding these indicators can help doctors predict how well a patient might recover and manage their treatment more effectively. Who this helps: This helps patients who have had a stroke and their doctors in making better treatment decisions.

Plain English
This study looked at using a medication called rt-PA to treat patients with acute ischemic stroke in Russia. Out of 14 patients treated, 9 showed improvement by the end of the first day, and 7 were doing well after three months. While some patients experienced bleeding, most cases were mild and didn't cause further issues, showing that this treatment can greatly help recovery from strokes. Who this helps: Patients suffering from ischemic stroke.

Plain English
This study looked at a treatment called selective intra-arterial thrombolysis (IAT) for patients who have had a stroke caused by a blocked large blood vessel. The researchers treated two patients, one who improved from a score of 13 to 8 (a 5-point decrease) and another from 20 to 14 (a 6-point decrease) on a stroke severity scale, after receiving IAT. These findings show that IAT can be very effective, even when given several hours after a stroke starts, which is important for helping patients recover better. Who this helps: This helps stroke patients by improving their chances of recovery after a large vessel blockage.